Navigation Links
Harvard School of Public Health awarded $20 million CDC grant to study HIV prevention in Botswana

Boston, MA A new four-year, $20 million grant from the U.S. Centers for Disease Control and Prevention (CDC) will enable Harvard School of Public Health (HSPH) researchers to evaluate the impact and cost-effectiveness of a unique combination of HIV prevention strategies in Botswana. The CDC grant is part of a U.S. President's Emergency Plan for AIDS Relief (PEPFAR) initiative that commits $45 million to examine the effectiveness of combination approaches to HIV prevention over four years. The largest evaluation of its kind, the research initiative is poised to help partner countries strengthen their efforts to prevent new HIV infections and save lives. For more information about the combination prevention initiative, visit:

Principal investigator Max Essex, professor of health sciences and chair of the Harvard School of Public Health AIDS Initiative, and co-principal investigator Victor De Gruttola, professor of biostatistics and chair of the Department of Biostatistics at HSPH, predict that their prevention strategies can reduce HIV infection by at least 50 percent.

Notably, one aspect of the study includes a focused effort to prevent HIV transmission by individuals with a high viral load. "This is the subset of people most likely to transmit the virus," said Essex.

He and his colleagues believe that targeting those mostly likely to transmit HIV can greatly reduce disease incidence and be cost-effective. Essex noted that some researchers have advocated supplying all HIV-positive individuals in a particular group with antiretrovirals, but covering all infected people in populations with high rates of infection can be prohibitively expensive for governments in developing countries.

Another unique aspect of the HSPH study is that researchers will study viral gene signatures (the genomic fingerprint of a virus) to determine the effectiveness of targeting individuals with high viral loads. Using this method can indicate whether new infections originated within a particular village, for example. Identifying viral gene signatures could also determine how much the study interventions are able to reduce infections that can be traced to individuals with high viral loads.

Researchers will also analyze cost savings realized from using the prevention strategies in the study. "The hope is that the strategies will help countries cut costs dramatically," said Essex. "Conducting a study of this type in southern Africa is more logical because HIV infection rates are much higher than those in the U.S. and the results can be obtained sooner."

The study will be conducted in collaboration with the Botswana Harvard AIDS Institute Partnership (BHP), a 15-year-old collaborative research and training initiative between the Harvard School of Public Health AIDS Initiative and the Botswana Ministry of Health.

In spite of Botswana's significant efforts to curtail the incidence of HIV/AIDS, 25 percent of adults in this southern African country are HIV-positive. To home in on ways to optimize HIV prevention strategies, HSPH and BHP researchers will conduct a randomized study of nearly 50,000 people22,000 in the village of Mochudi, and roughly 28,000 in 16 rural communities. HSPH and BHP researchers, working with Botswana's Ministry of Health, will examine the effects of combining a number of prevention strategies over a four-year period. In addition to treating high viral load, the interventions include

  • Testing and counseling more than 70% of 18- to 49-year-old adults

  • Voluntary circumcision of more than 70% of 18- to 49-year-old adult males not infected with HIV

  • Providing more than 90% of HIV-infected adults with antiretroviral therapy

  • Providing antiretrovirals to 95% of HIV-infected pregnant women in order to prevent disease transmission to their children

These interventions have not been adequately evaluated in combination, said Essex. Using a number of prevention strategies together at the same time should also test whether they have a synergistic effect. According to co-principal investigator De Gruttola, "Studying people as members of village communities rather than as isolated subjects allows for mathematical modeling of the effects of combination prevention strategies in the settings in which they will actually be used."


Contact: Todd Datz
Harvard School of Public Health

Related biology news :

1. Harvard scientists see the early cellular cause of dry eye disease for the first time
2. Harvards engineering school receives $100,000 Grand Challenges Explorations grant
3. Harvards Wyss Institute develops technology to produce sugar from photosynthetic bacteria
4. Harvards Wyss Institute uses natures design principles to create specialized nanofabrics
5. Phosphorous in sodas and processed foods accelerates signs of aging say Harvard scientists
6. New discovery by Harvard scientists aims to correct cellular defects leading to diabetes
7. Harvard research team receives $10M NSF grant to develop small-scale mobile robotic devices
8. Harvard scientists solve mystery about why HIV patients are more susceptible to TB infection
9. Duke, Harvard researchers to monitor bonobo reintroduction
10. Harvard scientist says we are what we eat -- and what we cook
11. Organizational Change Management for Sustainability: The Harvard Case Study
Post Your Comments:
(Date:11/19/2015)...  Although some 350 companies are actively involved in ... companies, according to Kalorama Information. These include Roche Diagnostics, Hologic, ... share of the 6.1 billion-dollar molecular testing market, according ... Molecular Diagnostic s .    ... by one company and only a handful of companies ...
(Date:11/17/2015)... , November 17, 2015 Paris ...   --> Paris from 17 th ... DERMALOG, the biometrics innovation leader, has invented the first combined ... on the same scanning surface. Until now two different scanners ... one scanner can capture both on the same surface. ...
(Date:11/17/2015)... Nov. 17, 2015 Pressure BioSciences, Inc. (OTCQB: ... development and sale of broadly enabling, pressure cycling technology ... industry, today announced it has received gross proceeds of ... Private Placement (the "Offering"), increasing the total amount raised ... more additional closings are expected in the near future. ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... ANGELES and HOLLISTON, Mass. ... Technology, Inc. (Nasdaq: HART ), a biotechnology company ... that CEO Jim McGorry will present at ... December 1, 2015 at 2:30 p.m. PT. The presentation ... below) for 30 days. Management will also be available ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... the Organization of Black Aerospace Professionals (OPBAP) has been formalized with the signing ... AMA team leaders met with OPBAP leaders Capt. Karl Minter and Capt. Albert ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... featured on AngelList early in their initial angel funding process. Now, they are ... individuals looking to make early stage investments in the microbiome space. In ...
(Date:11/24/2015)... SUNNYVALE, Calif. , Nov. 24, 2015 ... executives will be speaking at the following conference, and ... New York, NY      Tuesday, December 1, ... New York, NY      Tuesday, December 1, ...      Piper Jaffray Healthcare Conference, New York, NY ...
Breaking Biology Technology: